Biosimilars: Where Do We Stand?
Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, what are the ethical implications of these products? How will they impact clinical supply chain? What are the financial implications? Join a panel of experts as they explore these and other questions on biosimilars during this luncheon seminar.
Amir Emamifar, PharmD - Associate Administrator Pharmaceutical Services, Emory Healthcare
Yaniv Heled, JSD, LLM - Assistant Professor of Law, Georgia State University College of Law
Ashish Dugar PhD, MBA - Head, Medicines Development Group, Biosimilars Business Unit, Pfizer
Joel Zivot, MD, FRCP – Assistant Professor Anesthesiology & Surgery, Emory University School of Medicine, and Medical Director, Cardiothoracic ICU, Emory University Hospital Midtown
1.5 hours ACHE Qualified Education Credit (formerly “Category 2”)
Download the Flyer for more details & speaker biographies
Registrations for this event are being collected by the Georgia Association of Healthcare Executives. CLICK HERE TO REGISTER.
ACHE/GaBio Member ..... $35
Non-Member ................ $45
Student Member .......... $20
Student Non-Member..... $25
For information contact: GAHE Administrator Karen Manno or call 678-264-8354
A joint program with the Georgia Association of Healthcare Executives
- Workflow Status: Published
- Created By: Colly Mitchell
- Created: 09/17/2012
- Modified By: Fletcher Moore
- Modified: 10/07/2016